SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-064507
Filing Date
2021-11-15
Accepted
2021-11-15 17:06:30
Documents
2
Period of Report
2021-11-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1588
2 POA DOCUMENT poa.txt EX-24 2589
  Complete submission text file 0001209191-21-064507.txt   5754
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALLOVIR, INC. 139 MAIN STREET, SUITE 500 CAMBRIDGE MA 02142
Business Address
Brainard Diana (Reporting) CIK: 0001818070 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-24006 | Film No.: 211412207